Market Trends Metsera prices IPO at $18 per share (Pending:MTSR)By admin8996erT0allJanuary 31, 2025 2d illustrations and photos/iStock via Getty Images Clinical-stage biotechnology company Metsera (MTSR) priced its initial public offering of ~15.28M shares…
Market Trends Obesity drug developer Metsera files for $100M IPO (IPO:NYSEARCA)By admin8996erT0allJanuary 13, 2025 2d illustrations and photosMetsera (MTSR), which is developing ultra-long-acting drugs for the treatment of obesity, has filed for a $100M…
